Assyro AI

Orange Book product · Brand (NDA)

FOSRENOL

LANTHANUM CARBONATE

Brand (NDA)NDA 204734RX TAKEDA PHARMS USA

At a glance

Sep 24, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 24, 2014

    11 yr 11 mo ago

  2. Today

  3. Patent 8980327 expires

    Listed drug product patent expiration.

    Dec 01, 2030

    in 4 yr 6 mo

  4. Patent 9023397 expires

    Listed drug product patent expiration.

    Dec 01, 2030

    in 4 yr 6 mo

Pharmaceutical detail

Active ingredient

LANTHANUM CARBONATE

Strength

EQ 1GM BASE

Dosage form

POWDER

Route

ORAL

TE code

Not listed

Application

NDA 204734

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8980327Dec 01, 2030in 4 yr 6 mo
Product
9023397Dec 01, 2030in 4 yr 6 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.